Double Medical(SZ:002901) Sou Hu Cai Jing·2025-12-02 13:44Core Viewpoint - The stock of Dabo Medical (002901) has shown a decline in price and mixed capital flow, with significant net outflows from retail investors, while institutional investors have shown some interest [1][3]. Group 1: Stock Performance - As of December 2, 2025, Dabo Medical's stock closed at 48.96 yuan, down 1.01%, with a turnover rate of 0.81% and a trading volume of 23,400 hands, resulting in a transaction amount of 116 million yuan [1]. - The net inflow of main funds on December 2 was 8.74 million yuan, accounting for 7.54% of the total transaction amount, while retail investors had a net outflow of 8.20 million yuan, representing 7.08% of the total [1]. Group 2: Financial Metrics - Dabo Medical's total market value is 20.27 billion yuan, with a net asset of 3.44 billion yuan and a net profit of 425 million yuan, ranking 12th, 43rd, and 17th respectively in the medical device industry [2]. - The company reported a year-on-year revenue increase of 22.69% for the first three quarters of 2025, with a total revenue of 1.876 billion yuan and a net profit increase of 77.03% to 425 million yuan [2]. - The gross profit margin stands at 71.23%, significantly higher than the industry average of 51.22%, indicating strong profitability [2]. Group 3: Institutional Ratings - In the last 90 days, one institution has issued a buy rating for Dabo Medical, indicating some level of confidence in the stock's potential [3].